Cargando…
Repairing the Aged Parkinsonian Striatum: Lessons from the Lab and Clinic
The primary risk factor associated with Parkinson's disease (PD) is advanced age. While there are symptomatic therapies for PD, efficacy of these eventually wane and/or side-effects develop over time. An alternative experimental therapy that has received a great deal of attention over the past...
Autores principales: | Mercado, Natosha M, Collier, Timothy J, Freeman, Thomas, Steece-Collier, Kathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243125/ https://www.ncbi.nlm.nih.gov/pubmed/28111608 http://dx.doi.org/10.4172/2155-9899.1000476 |
Ejemplares similares
-
Cell therapy for Parkinson's disease: Why it doesn't work every time
por: Collier, Timothy J., et al.
Publicado: (2019) -
Is Alpha-Synuclein Loss-of-Function a Contributor to Parkinsonian Pathology? Evidence from Non-human Primates
por: Collier, Timothy J., et al.
Publicado: (2016) -
Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia
por: Steece‐Collier, Kathy, et al.
Publicado: (2019) -
Downregulation of striatal Ca(V)1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age
por: Caulfield, Margaret E., et al.
Publicado: (2023) -
Biochemical Changes Induced by Embryonic Substantia Nigra Transplanted to the Striatum of Parkinsonian Monkeys
por: Elsworth, J. D., et al.
Publicado: (1992)